You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-tumor necrosis factor alpha monoclonal antibody

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

Recruiting
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Helsinki, Finland
    Docrates Cancer Center
Jul 12, 2022

Cardiac Functions in Type 1 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • transthoracic echocardiography
  • (no location specified)
Nov 12, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • Inflammation
  • (no location specified)
Nov 21, 2023

Anti-citrullinated Protein Antibody Status on Treatment Response

Completed
  • Rheumatoid Arthritis
  • Non-Interventional
  • Canberra City, Australia
    (unnamed)
Feb 22, 2022

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Solid Tumor Trial (GS-4528, Zimberelimab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Apr 21, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

Active, not recruiting
  • Colitis,Ulcerative
  • Discontinuation of anti-TNF treatment
  • Continuation of anti-TNF treatment
  • Alesund, Norway
  • +18 more
Jul 13, 2022

Rheumatoid Arthritis Trial in Copenhagen (Exercise, No exercise)

Recruiting
  • Rheumatoid Arthritis
  • Exercise
  • No exercise
  • Copenhagen, Denmark
    Rigshospitalet
Feb 3, 2022

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

Completed
  • Early Childhood Caries
  • ELISA
  • Aydın, Turkey
    Sultan KELEŞ
Oct 20, 2021

Advanced Solid Tumor Trial in Bengbu (HB0030 injection)

Recruiting
  • Advanced Solid Tumor
  • HB0030 injection
  • Bengbu, Anhui, China
    the First Affiliated Hospital of Bengbu Medical College
Jan 20, 2023

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

Solid Tumor, Adult Lymphoma Trial (HLX51)

Not yet recruiting
  • Solid Tumor, Adult Lymphoma
  • (no location specified)
Mar 15, 2023

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Infliximab: Adalimumab; Etanercept;
  • Sulaymaniyah, Kurdistan Region, Iraq
    Hiwa Khidhir Saaed
May 12, 2022

Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 10, 2022

Rates of Dementia and Alzheimer's Disease in Participants

Completed
  • Dementia
  • Alzheimer Disease
  • Titusville, New Jersey
    Janssen R&D
Oct 15, 2021

Solid Tumor Trial (IN10018, Nab-paclitaxel, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Aug 1, 2023

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Patients With Advanced Solid Tumors Trial in Shanghai (ICP-189)

Not yet recruiting
  • Patients With Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
May 8, 2022

Locally Advanced/Metastatic Solid Tumors Trial (PE0116&PE0105)

Not yet recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • (no location specified)
Mar 24, 2023